Calcium Channel, Voltage-Dependent, beta 2 Subunit (CACNB2) Peptid
CACNB2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle CACNB2 Produkte
- CACNB2 (Calcium Channel, Voltage-Dependent, beta 2 Subunit (CACNB2))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- HLADYLEAYW KATHPPSSSL PNPLLSRTLA TSSLPLSPTL ASNSQGSQGD
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody,
Alternative Names: CACNB2 control peptide, CACNB2 antibody Blocking Peptide, Anti-CACNB2 Blocking Peptide, Calcium Channel Voltage-Dependent Beta 2 Subunit Blocking Peptide, CACNLB2 Blocking Peptide, FLJ23743 Blocking Peptide, MYSB Blocking Peptide, CACNB2, CACNB-2, CACNB 2, CACNB-2 Blocking Peptide, CACNB 2 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- CACNB2 (Calcium Channel, Voltage-Dependent, beta 2 Subunit (CACNB2))
- Synonyme
- CACNLB2 Peptide, CAVB2 Peptide, MYSB Peptide, AW060387 Peptide, CAB2 Peptide, Cavbeta2 Peptide, Cchb2 Peptide, Cacnlb2 Peptide, Cacnb2 Peptide, CACNB2 Peptide, CACNB2.2 Peptide, cacnb2a Peptide, im:7141271 Peptide, si:dkey-32m20.2 Peptide, calcium voltage-gated channel auxiliary subunit beta 2 Peptide, calcium channel, voltage-dependent, beta 2 subunit Peptide, calcium channel, voltage-dependent, beta 2b Peptide, CACNB2 Peptide, Cacnb2 Peptide, cacnb2b Peptide
- Hintergrund
- CACNB2 contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting. Defects in CACNB2 are the cause of Brugada syndrome type 4 (BRS4).
- Molekulargewicht
- 68 kDa
-
Sie sind hier:
